Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04894669 · ClinicalTrials.gov registry record
Convenience Sample Data Collection for INVSENSOR00045
A clinical trial, sponsored by Masimo Corporation.
- Terminated
- Registry status
- 7
- Enrollment target
NCT04894669: Clinical Trial study, sponsored by Masimo Corporation.
NCT04894669 is a clinical trial that was terminated before completion, run by Masimo Corporation. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04894669 was terminated before completion, sponsored by Masimo Corporation.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This clinical investigation is to collect data to provide additional support for form, fit, and function of INVSENSOR00045 in the neonatal clinical environment when used by hospital's personnel and reference co-oximeter.
Primary Outcome
To observe form, fit, and function of the INVSENSOR00045 sensors in the neonatal population with convenience sampling in a clinical environment. Data collected using the sensors will be compared to the reference values (RMS).
Interventions
- DEVICE INVSENSOR00045
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-06-11 |
| Est. Completion | 2023-05-21 |
Why NCT04894669 stopped before completion
NCT04894669 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which INVSENSOR00045 is the first listed.
NCT04894669 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04894669 about?
NCT04894669 is a clinical study titled "Convenience Sample Data Collection for INVSENSOR00045". This clinical investigation is to collect data to provide additional support for form, fit, and function of INVSENSOR00045 in the neonatal clinical environment when used by hospital's personnel and reference co-oximeter.
What is the current status of trial NCT04894669?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2021-06-11. Estimated completion is 2023-05-21.
What interventions are being tested in trial NCT04894669?
The interventions under investigation include: INVSENSOR00045 (DEVICE).
Who is sponsoring clinical trial NCT04894669?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI